Darius Babusis
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 20
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 6
- HIV/AIDS Research and Interventions 5
-
- Biochemical and Molecular Research 6
- Co-authors
- Adrian S. Ray (22 shared papers)Tomáš Cihlář (13 shared papers)Joy Y. Feng (10 shared papers)Danielle Porter (5 shared papers)Ariane J. Brown (1 shared paper)Alexandra Schäfer (1 shared paper)Stephanie A. Montgomery (1 shared paper)Mark R. Denison (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Nature Communications (3 papers)Antiviral Research (3 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Darius Babusis
44 papers receiving 2.8k citations
Darius Babusis's Hit Papers
Peers
Comparison fields: 5 of 124
- Infectious Diseases 1.7k
- Virology 183
- Hepatology 223
- Neurology 314
- Epidemiology 416
Countries citing papers authored by Darius Babusis
This map shows the geographic impact of Darius Babusis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darius Babusis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darius Babusis more than expected).
Fields of papers citing papers by Darius Babusis
This network shows the impact of papers produced by Darius Babusis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darius Babusis. The network helps show where Darius Babusis may publish in the future.
Co-authors
The 25 scholars most cited alongside Darius Babusis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Hit paper breakdown → | 2020 | 1274 |
| 2 | 2009 | 169 | |
| 3 | 2015 | 139 | |
| 4 | 2003 | 123 | |
| 5 | 2007 | 117 | |
| 6 | 2012 | 103 | |
| 7 | 2021 | 100 | |
| 8 | 2012 | 93 | |
| 9 | 2013 | 79 | |
| 10 | 2021 | 76 | |
| 11 | 2015 | 63 | |
| 12 | 2009 | 60 | |
| 13 | 2012 | 53 | |
| 14 | 2020 | 43 | |
| 15 | 2004 | 34 | |
| 16 | 2013 | 33 | |
| 17 | 2014 | 31 | |
| 18 | 2007 | 28 | |
| 19 | 2012 | 28 | |
| 20 | 2018 | 26 |
About Darius Babusis
Darius Babusis is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Hepatology and Virology, having authored 45 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), Hepatitis C virus research (11 papers), HIV Research and Treatment (8 papers), Hepatitis B Virus Studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers), Biochemical and Molecular Research (6 papers) and HIV/AIDS Research and Interventions (5 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (183 citations), Hepatology (223 citations), Neurology (314 citations) and Epidemiology (416 citations). Darius Babusis has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Adrian S. Ray, Tomáš Cihlář, Joy Y. Feng, Danielle Porter, Ariane J. Brown, Alexandra Schäfer, Stephanie A. Montgomery, Mark R. Denison, Sarah R. Leist and Amy Sims. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Nature Communications, Antiviral Research and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.